title: Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
authors.affiliation: Dermatology Unit, Hospital General de México, México D.F.
authors.forename: A
authors.initials: A
authors.lastname: Bonifaz
authors.forename: A
authors.initials: A
authors.lastname: Guzmán
authors.forename: C
authors.initials: C
authors.lastname: Garcia
authors.forename: J
authors.initials: J
authors.lastname: Sosa
authors.forename: A
authors.initials: A
authors.lastname: Saúl
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy / Q000503:physiopathology; D006229:Hand Dermatoses / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; C036596:bifonazole